Skip to content
+1-310-730-5609inquiry@biovinc.com
Linkedin page opens in new window
Bone Targeted Therapeutics and Diagnostics
Biovinc Research & Development
Bone Targeted Therapeutics and Diagnostics
  • Home
  • Products
    • Fluorescent Imaging Probes
    • Custom Synthesis
    • Special Offers
      • Special “Cancer Discovery” Discount
  • Research
  • Resources
    • Bisphosphonates 101
    • Consulting Services
    • Preclinical Services
    • Protocols
    • References
  • Investors
  • News
  • Contact Us
  • Cart
My Account
  • Home
  • Products
    • Fluorescent Imaging Probes
    • Custom Synthesis
    • Special Offers
      • Special “Cancer Discovery” Discount
  • Research
  • Resources
    • Bisphosphonates 101
    • Consulting Services
    • Preclinical Services
    • Protocols
    • References
  • Investors
  • News
  • Contact Us
  • Cart

Daily Archives: March 15, 2017

You are here:
  1. Home
  2. 2017
  3. March
  4. 15

nih-funding-support_reduced-size-1024x683

BioVinc Receives an SBIR Phase II Grant from the National Institutes of Health

Funding infoBy BioVincMarch 15, 2017

BioVinc Receives an SBIR Phase II Grant from the National Institutes of Health BioVinc is pleased to announce that it has been awarded an SBIR Phase II grant from the National Institutes of Health (NIH/NIDCR). This grant will facilitate research and development towards the prevention/treatment of the very devastating dental affliction: osteonecrosis of the jaw…

Contact Information

BioVinc

2265 E. Foothill Blvd.
Pasadena, CA, 91107
+1-310-730-5609
inquiry@biovinc.com
What We Do
  • Commercialized Products
  • Research & Development
  • Preclinical Services
  • Consulting Services

Copyright © 2020 - BioVinc. All Rights Reserved.

Go to Top